Besse B - Search Results

1

Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.

Remon J, Swalduz A, Planchard D, Ortiz-Cuaran S, Mezquita L, Lacroix L, Jovelet C, Rouleau E, Leonce C, De Kievit F, Morris C, Jones G, Mercier K, Howarth K, Green E, Pérol M, Saintigny P, Besse B. Remon J, et al. Among authors: besse b. PLoS One. 2020 Jun 11;15(6):e0234302. doi: 10.1371/journal.pone.0234302. eCollection 2020. PLoS One. 2020. PMID: 32525942 Free PMC article.

2

Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.

Saintigny P, Besse B, Callard P, Vergnaud AC, Czernichow S, Colombat M, Girard P, Validire P, Breau JL, Bernaudin JF, Soria JC. Saintigny P, et al. Among authors: besse b. Clin Cancer Res. 2007 Aug 15;13(16):4825-31. doi: 10.1158/1078-0432.CCR-06-3061. Clin Cancer Res. 2007. PMID: 17699861

3

[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].

Italiano A, Besse B, Planchard D, Soria JC. Italiano A, et al. Among authors: besse b. Bull Cancer. 2007;94(7 Suppl):F177-88. Bull Cancer. 2007. PMID: 17964994 Review. French.

4

[Angiogenesis targeting in lung cancers].

Planchard D, Besse B. Planchard D, et al. Among authors: besse b. Bull Cancer. 2007;94(7 Suppl):F217-22. Bull Cancer. 2007. PMID: 17964999 Review. French.

5

Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers.

Mountzios G, Planchard D, Besse B, Validire P, Girard P, Devisme C, Dimopoulos MA, Soria JC, Fouret P. Mountzios G, et al. Among authors: besse b. Clin Cancer Res. 2008 Jul 1;14(13):4096-102. doi: 10.1158/1078-0432.CCR-07-4150. Clin Cancer Res. 2008. PMID: 18593986

6

[Towards customized therapy for non small cell lung cancer].

Planchard D, Besse B. Planchard D, et al. Among authors: besse b. Bull Cancer. 2008 Oct;95(10):951-8. doi: 10.1684/bdc.2008.0719. Bull Cancer. 2008. PMID: 19004725 French.

7

[Lung cancer in never smoker: Epidemiology, molecular profiles and treatment].

Hadoux J, Besse B, Planchard D. Hadoux J, et al. Among authors: besse b. Presse Med. 2011 Apr;40(4 Pt 1):371-8. doi: 10.1016/j.lpm.2011.02.001. Epub 2011 Mar 21. Presse Med. 2011. PMID: 21420271 Review. French.

8

Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.

Friboulet L, Barrios-Gonzales D, Commo F, Olaussen KA, Vagner S, Adam J, Goubar A, Dorvault N, Lazar V, Job B, Besse B, Validire P, Girard P, Lacroix L, Hasmats J, Dufour F, André F, Soria JC. Friboulet L, et al. Among authors: besse b. Clin Cancer Res. 2011 Sep 1;17(17):5562-72. doi: 10.1158/1078-0432.CCR-11-0790. Epub 2011 Jul 12. Clin Cancer Res. 2011. PMID: 21750204

9

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.

Besse B, Planchard D, Veillard AS, Taillade L, Khayat D, Ducourtieux M, Pignon JP, Lumbroso J, Lafontaine C, Mathiot C, Soria JC. Besse B, et al. Lung Cancer. 2012 Apr;76(1):78-83. doi: 10.1016/j.lungcan.2011.09.006. Epub 2011 Dec 18. Lung Cancer. 2012. PMID: 22186627 Clinical Trial.

10

The challenge to bring personalized cancer medicine from clinical trials into routine clinical practice: the case of the Institut Gustave Roussy.

Arnedos M, André F, Farace F, Lacroix L, Besse B, Robert C, Soria JC, Eggermont AM. Arnedos M, et al. Among authors: besse b. Mol Oncol. 2012 Apr;6(2):204-10. doi: 10.1016/j.molonc.2012.02.008. Epub 2012 Mar 16. Mol Oncol. 2012. PMID: 22483534 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters